Esperion Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Esperion Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • Esperion Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $2.58M.
  • Esperion Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $4.95M.
  • Esperion Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$156M, a 13.3% increase from 2022.
  • Esperion Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$180M, a 20.8% increase from 2021.
  • Esperion Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$227M, a 86.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$156M +$23.9M +13.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$180M +$47.2M +20.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$227M -$105M -86.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-21
2020 -$121M -$28.3M -30.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-22
2019 -$93.1M +$111M +54.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 -$205M -$35.6M -21.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 -$169M -$92.8M -122% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$76.2M -$26.1M -52.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$50M -$13.8M -38.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
2014 -$36.2M -$13.5M -59.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2013 -$22.8M -$12.6M -123% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
2012 -$10.2M -$39.6K -0.39% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-10
2011 -$10.2M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.